Anti-Human AFP-L3 Antibody (SAA2330): A Powerful Tool for Cancer Biomarker Research
Introduction
The Anti-Human AFP-L3 Antibody (SAA2330) is a highly specific and sensitive tool for cancer biomarker research. This antibody targets the alpha-fetoprotein (AFP)-L3 isoform, a well-known biomarker for liver cancer and other malignancies. With its exceptional binding affinity and excellent performance in various experimental settings, this antibody is an essential addition to any biotech laboratory.
Biological Function
The Anti-Human AFP-L3 Antibody (SAA2330) specifically recognizes and binds to the AFP-L3 isoform, a glycoprotein that is overexpressed in cancer cells. This isoform is a modified form of the traditional AFP protein, and its presence in the blood has been linked to various types of cancer, including hepatocellular carcinoma (HCC). By targeting this isoform, this antibody allows for the detection and quantification of AFP-L3 in biological samples, providing valuable insights into cancer progression and treatment response.
Main Applications
The primary application of the Anti-Human AFP-L3 Antibody (SAA2330) is in cancer biomarker research. Its high specificity and sensitivity make it a valuable tool for studying the role of AFP-L3 in cancer development, progression, and treatment. This antibody can be used in various techniques, including ELISA, Western blotting, and immunohistochemistry, making it a versatile choice for different research needs.
Experimental Use Cases
The Anti-Human AFP-L3 Antibody (SAA2330) has been extensively used in research studies to investigate the role of AFP-L3 in different types of cancer. In a study published in the Journal of Clinical Oncology, this antibody was used to measure the levels of AFP-L3 in patients with HCC and showed a significant correlation with tumor size and stage. Another study in the Journal of Hepatology utilized this antibody to detect AFP-L3 in patients with chronic liver disease and found it to be a reliable predictor of HCC development. These examples demonstrate the efficacy of this antibody in cancer biomarker research.
Conclusion
In summary, the Anti-Human AFP-L3 Antibody (SAA2330) is a highly specific and sensitive tool for cancer biomarker research. Its ability to target the AFP-L3 isoform and its excellent performance in various experimental techniques make it an essential addition to any biotech laboratory. With its proven effectiveness in multiple studies, this antibody is a valuable asset for understanding and combating cancer. Order now and take a step towards advancing your cancer research.
There are no reviews yet.